| Ms Nancy Ann Lawhon, LPN | |
|
393 County Road 12, Proctorville, OH 45669-8455 | |
| (740) 886-1025 | |
| (740) 886-1025 |
| Full Name | Ms Nancy Ann Lawhon |
|---|---|
| Gender | Female |
| Speciality | Licensed Vocational Nurse |
| Location | 393 County Road 12, Proctorville, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568493302 | NPI | - | NPPES |
| 2576181 | Other | OH | CARE STAR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164X00000X | Licensed Vocational Nurse | PN.104178 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Nancy Ann Lawhon, LPN 393 County Road 12, Proctorville, OH 45669-8455 Ph: (740) 886-1025 | Ms Nancy Ann Lawhon, LPN 393 County Road 12, Proctorville, OH 45669-8455 Ph: (740) 886-1025 |
News Archive
A brand new study of 200 dementia sufferers in Norway reveals that almost all experience greater peace of mind and increased levels of physical activity using GPS devices.
This post on RH Reality Check examines a Ugandan court case "alleging that the Ugandan government failed to protect the ... constitutional rights to life and health [of several women] by allowing them to die in ill-equipped and poorly managed public hospitals, or failing to provide them with basic maternal care."
A Yale Cancer Center research team has identified that two genes, NR4A1 and ABC transporters, mark a distinct subset of quiescent T cells within human tissues, and have developed methods to mobilize them into circulation for potential application in adoptive T cell therapy of cancer.
Lawmakers in recent months "have stirred up a witch's brew of initiatives that is cause for some concern - not only for the biotech industry, but for all Americans," James Mullen, president and CEO of Biogen and chair of the Biotechnology Industry Organization, writes in a Wall Street Journal opinion piece.
Kidney histology and function three years after transplantation are better in kidney-transplant patients who remain on sirolimus-based therapy following early withdrawal of cyclosporine than in patients who continue on this calcineurin inhibitor, according to a new study published in the American Journal of Transplantation.
› Verified 5 days ago